Retraction Note: Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study
Suchandra Chowdhury, Suman Bandyopadhyay, Chandan Mandal, Sarmila Chandra, Chitra Mandal · 2026
Read Retraction Note: Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study by Suchandra Chowdhury, Suman Bandyopadhyay, Chandan Mandal, Sarmila Chandra, Chitra Mandal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13411989.txt.
Description
A 2026 retraction note from the editors of BMC Cancer withdraws a 2008 article by Suchandra Chowdhury and colleagues on blood markers in children with acute lymphoblastic leukaemia. The original two-year follow-up study tracked 9-O-acetylated sialoglycoproteins alongside known CD antigens as an index of minimal residual disease. The journal states that its editors no longer trust the reported results or conclusions.
Concerns centred on images that look highly similar within the article and in another publication by the same group. Six figure pairings are listed, spanning diagnosis, treatment response, and later follow-up panels. The editors gave the authors a chance to answer the concerns, yet received no reply to their letters about the retraction.
Catalog record
| CREATOR | Suchandra Chowdhury, Suman Bandyopadhyay, Chandan Mandal, Sarmila Chandra, Chitra Mandal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |